27 min listen
Longer Time to Chemotherapy Linked to Worse Outcomes in Triple-Negative Disease
Longer Time to Chemotherapy Linked to Worse Outcomes in Triple-Negative Disease
ratings:
Length:
7 minutes
Released:
Dec 17, 2018
Format:
Podcast episode
Description
Dr. Zaida Morante, medical oncologist at Instituto Nacional de Enfermedades Neoplásicas in Lima, Peru, explains her research that found delaying chemotherapy for more than 30 days was associated with worse outcomes in women diagnosed with early-stage, triple-negative breast cancer. Triple-negative breast cancer is breast cancer that is estrogen-receptor-negative, progesterone-receptor-negative, and HER2-negative.
Listen to the podcast to hear Dr. Morante explain:
the design of the study
which outcomes delaying chemotherapy affected
possible explanations for why chemotherapy was delayed for some women
Listen to the podcast to hear Dr. Morante explain:
the design of the study
which outcomes delaying chemotherapy affected
possible explanations for why chemotherapy was delayed for some women
Released:
Dec 17, 2018
Format:
Podcast episode
Titles in the series (100)
Research Highlights From the San Antonio Breast Cancer Symposium, December 12, 2013: Our experts discuss the latest research out of SABCS 2013 by Breastcancer.org Podcast